DEVELOPMENT OF A TEMPERATURE-STABLE BROAD-SPECTRUM ANTIVIRAL FOR RESPIRATORY VIRAL PATHOGENS

$2,714,946FY2022Defense Health AgencyDOD

Hdt Bio Corp

Investigators

View source on USAspending →